Clinical Trial

Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer

Study acronym: DARTS
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to find out what effects of using adaptive radiotherapy to deliver chest radiation has on the ability to control lung cancer and side effects.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-06-28; most recent amendment 2025-06-10.
Status change: Not Yet Recruiting → Recruiting 2022-04-25
Trial Details
NCT Number NCT04952480
Lead Sponsor AHS Cancer Control Alberta
Conditions Small Cell Lung Cancer
Enrollment 31 participants
Start Date 2022-06-13
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-12